Gilead Sciences
GILD
#118
Rank
S$230.22 B
Marketcap
S$185.67
Share price
-2.14%
Change (1 day)
28.53%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): S$9.52

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$9.46. In 2025 the company made an earnings per share (EPS) of S$8.73 an increase over its 2024 EPS that were of S$0.48.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$9.529.07%
2025S$8.731702.63%
2024S$0.48-91.65%
2023S$5.8023.98%
2022S$4.68-25.86%
2021S$6.314850%
2020S$0.13-97.64%
2019S$5.400.9%
2018S$5.3618.71%
2017S$4.51-64.88%
2016S$12.85-18.45%
2015S$15.7555.28%
2014S$10.15296.02%
2013S$2.5617.89%
2012S$2.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.13 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.67-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.62-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.97 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.45 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$11.92 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.05-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$21.68 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.56-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA